Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Cell Mol Pharmacol 2023, Vol 7(2): 148
  • DOI: 10.4172/jcmp.1000148

Nanocarrier Transport and Reaction Modelling for Cancer Therapies Using Experimental and in Silico Methods

Benjamin Franklin, Rosalind Franklin and Sigmund Freud*
Department of Life Sciences, School of Pharmacy, Malaysia
*Corresponding Author : Sigmund Freud, Department of Life Sciences, School of Pharmacy, Malaysia, Email: sigmundfreud12@gmail.com

Received Date: Mar 27, 2023 / Published Date: Apr 25, 2023

Abstract

Nanocarriers composed of liposomes, micelles, polymeric nanoparticles and others have proven excellent possibilities in the discipline of centered drug delivery, in particular in most cancers therapy. Functionalisation of nanomaterials via simultaneous assembling of chemical moieties has been a approach of broad interest, to collect houses such as toughness in circulation, web site specificity and stimuli sensitivity. Imparting multifunctionality to nanocarriers controls their organic interplay in a preferred trend and enhances the efficacy of remedy and diagnostic protocols. Here, we try to evaluate the utility of a variety of nanocarrier structures for centered drug shipping and present day techniques for the improvement of multifunctionality on nanocarrier systems. Proteinbased nanocarriers have received vast interest as colloidal service structures for the shipping of anticancer drugs. Protein nanocarriers possess a variety of benefits consisting of their low cytotoxicity, ample renewable sources, excessive drug-binding capacity, and giant uptake into the focused tumor cells. Moreover, the special protein shape gives the opportunity of site-specific drug conjugation and tumor focused on the usage of a range of ligands enhancing the floor of protein nanocarriers.

Keywords: Hypertension; Angiotensin-converting enzyme; Blood pressure; Mechanisms of action

Citation: Franklin B, Franklin R, Freud S (2023) Nanocarrier Transport and Reaction Modelling for Cancer Therapies Using Experimental and in Silico Methods. J Cell Mol Pharmacol 7: 148. Doi: 10.4172/jcmp.1000148

Copyright: © 2023 Franklin B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top